Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
Frontiers in Cardiovascular Medicine · 20.03.2025 · 12
DOI: 10.3389/fcvm.2025.1546515 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 20.03.2025. Verfasst von Wang Dui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Rehabilitation, The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Baiyin, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
RNA therapeutics are emerging as a promising approach for cardiovascular diseases (CVDs) management, offering targeted gene regulation through modalities like mRNA, siRNA, and miRNA. In recent years, researchers have conducted a lot of research on the application of RNA therapeutics technology in the treatment of CVDs. Despite hurdles in off-target effects and immune responses, the clinical trial outcomes are encouraging. This review synthesizes the current progress in RNA therapeutics for CVDs, examining their mechanisms, advantages, and challenges in delivery and safety. We highlight the potential of personalized medicine, combination artificial intelligence (AI) and bioinformatics in advancing RNA therapeutics. The future of RNA therapeutics in CVDs is poised for significant impact, necessitating continued research and interdisciplinary collaboration to optimize these treatments and ensure patient safety and efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Rehabilitation, The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Baiyin, China.
- Department of Endocrinology, The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Baiyin, China.
- Cardiovascular Department, The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine, Baiyin, China.
Zitieren
APA
Dui, W., Xiaobin, Z., Haifeng, Z., Lijuan, D., Wenhui, H., Zhengfeng, Z., & Jinling, S. (2025). Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1546515
Vancouver
Dui W, Xiaobin Z, Haifeng Z, Lijuan D, Wenhui H, Zhengfeng Z, et al. Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1546515
BibTeX
@article{Dui2025,
author = {Dui, Wang and Xiaobin, Zhao and Haifeng, Zhang and Lijuan, Dang and Wenhui, Huang and Zhengfeng, Zhang and Jinling, Song},
title = {Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1546515}
}
EUVIMED